Jonathan D. Tward

University of Utah — United States

Medicine · Health Sciences

38h-index9.8kcitations256works13.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(112), Prostate Cancer Diagnosis and Treatment(97), Advanced Radiotherapy Techniques(32), Bladder and Urothelial Cancer Treatments(30), Cancer, Lipids, and Metabolism(21)

Publications256 total

Exploring Factors That Impact Genetic Counseling Referral and Uptake Using Learning Health Approaches
Learning Health Systems·2025Open Access
Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network·2025· 9 cited
Impact of locoregional treatment intensification in stampede high-risk M0 prostate cancer patients
Brachytherapy·2025Open Access
A Simple Two-Feature Model may Outperform Conventional Risk Classifiers for Metastasis in Prostate Cancer
International Journal of Radiation Oncology*Biology*Physics·2025
62P Prognostic plasma proteome-based nomogram in metastatic castrate-resistant prostate cancer (mCRPC)
ESMO Open·2025Open Access
Genomic Tumor Testing in NCCN Favorable and Unfavorable Intermediate-Risk Prostate Cancer Informs Treatment Intensity: Data from an Open Access Research Registry
International Journal of Radiation Oncology*Biology*Physics·2025
oDigital pathology biomarkers for guiding radiotherapy-based treatment concepts in prostate cancer − a systematic review and expert consensus
Radiotherapy and Oncology·2025· 2 cited
Enhancing inguinal tumor treatment outcomes with a customized 3D‐printed bolus
Journal of Applied Clinical Medical Physics·2025Open Access
Plasma proteome molecular sequencing–based prognostic nomogram in metastatic castrate-resistant prostate cancer (mCRPC).
Journal of Clinical Oncology·2025
Circulatory prostate cancer proteome landscapes and prognostic biomarkers in metastatic castrate resistant prostate cancer
Clinical Proteomics·2025· 1 citedOpen Access
PD13-02 PHASE II TRIAL OF IMAGE-GUIDED OLIGOMETASTATECTOMY AND RADIATION THERAPY IN RECURRENT PROSTATE CANCER (SOAR)
The Journal of Urology·2025
Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT)
Journal for ImmunoTherapy of Cancer·2025· 3 citedOpen Access
Using AI to identify optimal clinical, genomic, and radiographic prognostic features and novel risk classifiers compared to routinely available risk classifiers.
Journal of Clinical Oncology·2025· 1 cited
Plasma proteome-based integrative prognostic nomogram in metastatic castrate-resistant prostate cancer (mCRPC).
Journal of Clinical Oncology·2025
Phase II trial of image-guided oligometastatectomy and radiation therapy in recurrent prostate cancer (SOAR).
Journal of Clinical Oncology·2025
A Phase 2 Trial of Radium223 and Stereotactic Ablative Radiation Therapy in Hormone-Naïve Men with Oligometastatic Prostate Cancer to Bone: The RadSABR Study
International Journal of Radiation Oncology*Biology*Physics·2025· 2 cited
Prostate Posters PO0401
Brachytherapy·2024
PSOR12 Presentation Time: 12:25 PM
Brachytherapy·2024
SIOG2024-1-P-007 Adjuvant Nivolumab after Chemo-Radiation in Localized Muscle-Invasive Urothelial Cancer: Primary analysis of a singlearm phase II investigator-initiated trial (NEXT)
Journal of Geriatric Oncology·2024
Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital Histopathology
JCO Precision Oncology·2024· 14 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Dennis C. Shrieve(15), Elizabeth R. Plimack(11), Daniel E. Spratt(11), James A. Eastham(9), Eric M. Horwitz(9), Michael Kuettel(9), Julio M. Pow‐Sang(9), Mack Roach(9), Stan Rosenfeld(9), Edward M. Schaeffer(9), Sandy Srinivas(9), Dorothy A. Shead(8), Andrew J. Armstrong(7), Thomas A. Farrington(7), Robert E. Reiter(7), Anikó Szabó(7), David K. Gaffney(7), Brian J. Davis(6), Tanya B. Dorff(6), Joshua M. Lang(6)